Global Contrast Enhanced Ultrasound Market Size Study & Forecast by Product (Equipment, Nanoparticle & Molecule-targeted Microbubbles, Software), Application (Diagnostic, Therapeutic, CVDs, Liver, Kidney, Oncology) and Regional Forecasts 2025-2035

The Global Contrast Enhanced Ultrasound Market is valued approximately at USD 1.58 billion in 2024 and is anticipated to grow at a robust CAGR of 6.10% over the forecast period 2025-2035. Contrast-enhanced ultrasound (CEUS) is a revolutionary imaging technology that leverages microbubbles and nanoparticle agents to enhance the visualization of blood flow and tissue vascularity, thereby improving diagnostic accuracy and enabling more precise therapeutic interventions. Its increasing adoption across diagnostic and therapeutic applications, particularly in oncology, cardiology, and liver and kidney assessments, is driving market expansion globally. Moreover, advancements in software integration and real-time imaging capabilities are significantly augmenting the clinical utility of CEUS, thereby creating substantial growth opportunities for key market players.

The surge in the prevalence of chronic diseases such as cardiovascular disorders, liver and kidney abnormalities, and various cancers is directly fueling the demand for contrast-enhanced ultrasound procedures. Hospitals, specialized clinics, and ambulatory surgical centers (ASCs) are increasingly investing in advanced CEUS equipment and related technologies to enhance diagnostic accuracy while reducing patient exposure to ionizing radiation. Technological innovations, including nanoparticle and molecule-targeted microbubbles, have further expanded the clinical applications of CEUS, offering higher sensitivity and specificity. Nevertheless, market growth may be moderated by the high cost of equipment and regulatory complexities associated with contrast agent approvals, alongside competition from alternative imaging modalities such as MRI and CT.

Regionally, North America dominated the CEUS market in 2025, driven by the well-established healthcare infrastructure, widespread adoption of advanced imaging technologies, and high incidence of cardiovascular diseases and cancer. Europe follows closely, with strong growth attributed to increased healthcare expenditure, government initiatives promoting early disease diagnosis, and growing awareness of non-invasive imaging technologies. The Asia Pacific region is projected to witness the fastest growth during the forecast period, propelled by rising healthcare demand from population growth, expanding hospital networks, and increased investment in medical imaging technologies across countries like China and India. Additionally, Latin America and the Middle East & Africa are anticipated to present lucrative opportunities due to improving healthcare infrastructure and growing adoption of advanced diagnostic modalities.

Major market players included in this report are:
• GE Healthcare
• Siemens Healthineers
• Bracco Imaging
• Lantheus Holdings, Inc.
• Philips Healthcare
• Fujifilm Holdings Corporation
• Samsung Medison
• Guerbet Group
• SonoVue
• Analogic Corporation
• Hitachi Medical Systems
• Mindray Medical International
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Acusphere, Inc.
• Canon Medical Systems Corporation

Global Contrast Enhanced Ultrasound Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa



The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

By Product:
• Equipment
• Nanoparticle & Molecule-targeted Microbubbles
• Software

By Application:
• Diagnostic
• Therapeutic
• Cardiovascular Diseases (CVDs)
• Liver
• Kidney
• Oncology

By End User:
• Hospitals
• Clinics
• Ambulatory Surgical Centers (ASCs)

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• RoE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more